ALONG COME STATIN DRUGS! · Parkinson's Resource Organization

ALONG COME STATIN DRUGS!

Category: Newsworthy Notes

Some 25 million Americans take these so-called “wonder drugs” to lower their “bad” cholesterol levels, but is this popular class of pharmaceuticals actually safe? NOPE!

There are over 900 studies proving the adverse effects of statin drugs, including anemia, chronic fatigue, acidosis, liver dysfunction, thyroid disruption, PARKINSON’S, Alzheimer’s, diabetes, and, yes … even CANCER! That’s right. The latest available science suggests that this supposedly artery-scouring miracle medication may significantly increase your risk of developing cancer.

Far from a miracle cure for heart disease, statin drugs come with a laundry list of side effects. These statin drug side effects are often ignored or glossed over as rare or exceptionally unlikely. Statin drugs, it turns out, are far riskier than you’ve likely been told. From a cancer risk perspective they’re one of the last drugs you’d ever want to take for improved quantity and quality of life.

There are two primary classes of cholesterol-lowering drugs currently on the market: fibrates and statins. Fibrates, which include drugs such as clofibrate (Atromid-S) and gemfibrozil (Lopid), represent what you might say was “phase one” of the pharmaceutical industry’s war on cholesterol. Phase two is the statin class, which includes drugs such as atorvastatin calcium (Lipitor), pravastatin sodium (Pravachol), and simvastatin (Zocor).

Excerpted from The Truth About Cholesterol, Statin Drugs, and Cancer by Ty Bollinger. TheTruthAboutCancer.com

Share This Article:

Google+

Contact Us

Address
Parkinson's Resource Organization
74785 Highway 111
Suite 208
Indian Wells, CA 92210

Local Phone
(760) 773-5628

Toll-Free Phone
(877) 775-4111

General Information
info@parkinsonsresource.org

 

Like! Subscribe! Share!

Did you know that you can communicate with us through Facebook, Twitter, LinkedIn, YouTube, and now Instagram?

PRIVACY POLICY TEXT

 

Updated: August 16, 2017